HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 185 filers reported holding HORIZON PHARMA PLC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $70,000 | -26.3% | 2,630 | -46.1% | 0.00% | – |
| Q4 2018 | $95,000 | -96.7% | 4,883 | -96.7% | 0.00% | -100.0% |
| Q3 2018 | $2,868,000 | +2.6% | 146,485 | -13.2% | 0.00% | 0.0% |
| Q2 2018 | $2,794,000 | +7661.1% | 168,750 | +6596.4% | 0.00% | – |
| Q1 2018 | $36,000 | -2.7% | 2,520 | 0.0% | 0.00% | – |
| Q4 2017 | $37,000 | +32.1% | 2,520 | +12.4% | 0.00% | – |
| Q3 2017 | $28,000 | -75.9% | 2,241 | -77.2% | 0.00% | – |
| Q2 2017 | $116,000 | -7.2% | 9,809 | +16.3% | 0.00% | – |
| Q1 2017 | $125,000 | -95.2% | 8,431 | -93.6% | 0.00% | -100.0% |
| Q4 2016 | $2,604,000 | -71.5% | 131,513 | -73.9% | 0.00% | -70.0% |
| Q3 2016 | $9,145,000 | -10.3% | 504,436 | -18.5% | 0.01% | -16.7% |
| Q2 2016 | $10,193,000 | -29.9% | 618,861 | -29.5% | 0.01% | -20.0% |
| Q1 2016 | $14,542,000 | -23.1% | 877,552 | +0.6% | 0.02% | -34.8% |
| Q4 2015 | $18,909,000 | -0.2% | 872,586 | -8.7% | 0.02% | -11.5% |
| Q3 2015 | $18,951,000 | -30.2% | 956,149 | +22.3% | 0.03% | -18.8% |
| Q2 2015 | $27,149,000 | +16.7% | 781,510 | -12.7% | 0.03% | +18.5% |
| Q1 2015 | $23,256,000 | +15.6% | 895,494 | -42.6% | 0.03% | +17.4% |
| Q4 2014 | $20,126,000 | +42.0% | 1,561,360 | +35.2% | 0.02% | +43.8% |
| Q3 2014 | $14,178,000 | – | 1,154,539 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FNY Investment Advisers, LLC | 144,340 | $16,698 | 9.92% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 45,559 | $3,145 | 0.01% |